A detailed history of Yhb Investment Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Yhb Investment Advisors, Inc. holds 5,392 shares of LLY stock, worth $4.12 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
5,392
Previous 4,646 16.06%
Holding current value
$4.12 Million
Previous $4.21 Million 13.55%
% of portfolio
0.4%
Previous 0.37%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$772.14 - $960.02 $576,016 - $716,174
746 Added 16.06%
5,392 $4.78 Million
Q2 2024

Aug 01, 2024

BUY
$724.87 - $909.04 $2.91 Million - $3.65 Million
4,015 Added 636.29%
4,646 $4.21 Million
Q1 2024

Aug 14, 2024

SELL
$592.2 - $792.28 $2.38 Million - $3.18 Million
-4,015 Reduced 86.42%
631 $490,000
Q1 2024

Apr 26, 2024

SELL
$592.2 - $792.28 $13,028 - $17,430
-22 Reduced 3.37%
631 $490,000
Q4 2023

Jan 29, 2024

BUY
$525.19 - $619.13 $23,108 - $27,241
44 Added 7.22%
653 $380,000
Q3 2023

Oct 23, 2023

BUY
$434.7 - $599.3 $13,910 - $19,177
32 Added 5.55%
609 $327,000
Q2 2023

Aug 10, 2023

SELL
$350.74 - $468.98 $472,446 - $631,716
-1,347 Reduced 70.01%
577 $270,000
Q1 2023

May 08, 2023

BUY
$310.63 - $364.82 $10,872 - $12,768
35 Added 1.85%
1,924 $660,000
Q4 2022

Jan 12, 2023

SELL
$321.55 - $374.67 $14,148 - $16,485
-44 Reduced 2.28%
1,889 $0
Q1 2022

Apr 14, 2022

BUY
$234.69 - $291.66 $24,407 - $30,332
104 Added 5.69%
1,933 $554,000
Q3 2021

Oct 28, 2021

BUY
$221.6 - $272.71 $9,972 - $12,271
45 Added 2.52%
1,829 $423,000
Q2 2021

Jul 15, 2021

SELL
$180.55 - $233.54 $2,888 - $3,736
-16 Reduced 0.89%
1,784 $410,000
Q4 2020

Jan 21, 2021

BUY
$130.46 - $172.63 $4,174 - $5,524
32 Added 1.81%
1,800 $304,000
Q3 2020

Nov 02, 2020

BUY
$146.22 - $169.13 $258,516 - $299,021
1,768 New
1,768 $262,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $727B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Yhb Investment Advisors, Inc. Portfolio

Follow Yhb Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yhb Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Yhb Investment Advisors, Inc. with notifications on news.